Kaye SB, et al. Clin. Cancer Res. (2012) cited as Ref 610 in DOI: 10.1038/s41392-020-0110-5 (Q9873)
Jump to navigation
Jump to search
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Kaye SB, et al. Clin. Cancer Res. (2012) cited as Ref 610 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Kaye SB
0 references
2012
0 references
Clin. Cancer Res.
0 references
18
0 references
A phase II randomized placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remission (English)
0 references
6509-6518
0 references
